Vir Biotechnology

Vir Biotechnology is an immunology company that leverages the immune system to develop therapies addressing unmet medical needs in infectious diseases and beyond. Its pipeline is built on two core platforms — a next-generation antibody platform and PRO-XTEN™, a protease-releasable masking technology — to rapidly identify, optimize and advance candidates to the clinic. Vir focuses on translating immunologic breakthroughs into treatments that improve patient outcomes and transform lives.